ReviewAdvanced pharmaceutical bulletin2024

Targeted Hybrid Nanocarriers as Co-Delivery Systems for Enhanced Cancer Therapy.

Joan Onyebuchi Erebor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.